Xeljanz 5 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM37N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,126
Award facts
- Contract value 100% obligated
- $18,126.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $18,126.32 firm fixed-price delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 9, 2026, for the supply of Xeljanz 5 mg tablets in quantities of 60 units. The contract is a non-set-aside award issued under a competitive process, with an ultimate completion date of January 12, 2026. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. (formerly Amerisourcebergen), a major pharmaceutical distributor and healthcare solutions provider serving federal government agencies.
This delivery order operates under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The underlying IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide. The contract supports critical federal medical procurement needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the company demonstrating consistent capability to fulfill federal requirements through open competition across diverse therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FM37N?
SPE2DR26FM37N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26FM37N worth?
The government has obligated $18,126 on SPE2DR26FM37N.
Is contract SPE2DR26FM37N an order under another contract?
Yes. SPE2DR26FM37N is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM37N competed?
The extent of competition for SPE2DR26FM37N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award